Risk of cancer recurrence. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Neoplastic Stem Cells Prostate Lymph Nodes Breast Tumor Cells, Cultured MCF-7 Cells Neoplastic Cells, Circulating HT29 Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases61

Neoplasm Recurrence, Local Recurrence Breast Neoplasms Prostatic Neoplasms Neoplasm Metastasis Urinary Bladder Neoplasms Colonic Neoplasms Stomach Neoplasms Neoplasm Invasiveness Neoplasms Lung Neoplasms Ovarian Neoplasms Colorectal Neoplasms Adenocarcinoma Disease Progression Rectal Neoplasms Lymphatic Metastasis Carcinoma Carcinoma, Squamous Cell Pancreatic Neoplasms Carcinoma, Lobular Liver Neoplasms Carcinoma, Transitional Cell Uterine Cervical Neoplasms Carcinoma, Ductal, Breast Genetic Predisposition to Disease Carcinoma, Non-Small-Cell Lung Bone Neoplasms Carcinoma, Hepatocellular Endometrial Neoplasms Head and Neck Neoplasms Esophageal Neoplasms Skin Neoplasms Cell Transformation, Neoplastic Neoplasms, Second Primary Mouth Neoplasms Thyroid Neoplasms Neoplasms, Hormone-Dependent Neoplasms, Glandular and Epithelial Postoperative Complications Obesity Adenoma Neovascularization, Pathologic Carcinoma, Small Cell Brain Neoplasms Carcinoma, Intraductal, Noninfiltrating Melanoma Neoplasms, Radiation-Induced Neoplasms, Multiple Primary Gastrointestinal Neoplasms Genital Neoplasms, Female Carcinoma in Situ Precancerous Conditions Neoplasm Seeding Sarcoma Pharyngeal Neoplasms Peritoneal Neoplasms Mammary Neoplasms, Experimental Carcinoma, Papillary Neoplastic Cells, Circulating Testicular Neoplasms

Chemicals and Drugs46

Tamoxifen Tumor Markers, Biological Antineoplastic Agents, Hormonal Prostate-Specific Antigen Receptors, Estrogen Cytochrome P-450 CYP2D6 Cancer Vaccines Receptors, Progesterone Antineoplastic Agents Selective Estrogen Receptor Modulators Receptor, erbB-2 Aromatase Inhibitors Fluorouracil Neoplasm Proteins Nitriles Receptors, Androgen Radiopharmaceuticals Fluorodeoxyglucose F18 Triazoles RNA, Messenger DNA, Neoplasm Tumor Suppressor Protein p53 Cisplatin RNA, Small Interfering Antigens, Neoplasm Antineoplastic Agents, Phytogenic Hydroxymethylglutaryl-CoA Reductase Inhibitors Paclitaxel Anticarcinogenic Agents Antibodies, Monoclonal MicroRNAs Ki-67 Antigen Carcinoembryonic Antigen Receptor, Epidermal Growth Factor Tumor Suppressor Proteins Antimetabolites, Antineoplastic Deoxycytidine Antibodies, Monoclonal, Humanized Taxoids RNA, Neoplasm DNA-Binding Proteins Nuclear Proteins Proto-Oncogene Proteins Androgens Transcription Factors BRCA2 Protein

Analytical, Diagnostic and Therapeutic Techniques and Equipment89

Prognosis Neoplasm Staging Follow-Up Studies Treatment Outcome Chemotherapy, Adjuvant Retrospective Studies Disease-Free Survival Prostatectomy Survival Analysis Survival Rate Risk Factors Mastectomy, Extended Radical Proportional Hazards Models Radiotherapy, Adjuvant Combined Modality Therapy Prospective Studies Early Detection of Cancer Kaplan-Meier Estimate Risk Assessment Predictive Value of Tests Risk Antineoplastic Combined Chemotherapy Protocols Cystoscopy Multivariate Analysis Mastectomy, Segmental Cohort Studies Gastrectomy Mastectomy Registries Ultrasound, High-Intensity Focused, Transrectal Gene Expression Profiling Cystectomy Sensitivity and Specificity Tomography, X-Ray Computed Odds Ratio Immunohistochemistry Positron-Emission Tomography Tissue Array Analysis Lymph Node Excision Incidence Questionnaires Oligonucleotide Array Sequence Analysis Reproducibility of Results Regression Analysis Reverse Transcriptase Polymerase Chain Reaction Analgesia, Epidural Randomized Controlled Trials as Topic Blood Transfusion ROC Curve Xenograft Model Antitumor Assays Neoplasm Grading Analysis of Variance Neoplasm Transplantation Models, Statistical Blotting, Western Radiotherapy Tumor Burden Clinical Trials as Topic Transplantation, Heterologous Biopsy Case-Control Studies Body Mass Index Polymerase Chain Reaction Mammography Logistic Models Obesity Molecular Targeted Therapy Drug Administration Schedule SEER Program Drug Screening Assays, Antitumor Catheter Ablation Radiotherapy Dosage Confidence Intervals Immunoenzyme Techniques Liver Transplantation Chi-Square Distribution Models, Biological Transfection Colonoscopy Palliative Care Probability Flow Cytometry Hepatectomy Biopsy, Needle Gene Knockdown Techniques Genetic Testing Mammary Neoplasms, Experimental Immunotherapy DNA Mutational Analysis

Psychiatry and Psychology3

Adaptation, Psychological Smoking Stress, Psychological

Phenomena and Processes41

Gene Expression Regulation, Neoplastic Risk Time Factors Sensitivity and Specificity Drug Resistance, Neoplasm Odds Ratio Postmenopause Cell Proliferation Genetic Predisposition to Disease Diet Mutation DNA Methylation Genotype Cell Survival Body Mass Index Cell Movement Down-Regulation Genes, BRCA1 Polymorphism, Genetic Obesity Dose-Response Relationship, Drug Cell Division Apoptosis Cell Cycle Promoter Regions, Genetic Cell Growth Processes Genes, Neoplasm Up-Regulation RNA Interference Chi-Square Distribution Transfection Gene Silencing Genes, Tumor Suppressor Genes, p53 Germ-Line Mutation Phenotype Probability Gene Expression Base Sequence Signal Transduction Genes, BRCA2

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life National Cancer Institute (U.S.)Age Distribution

Humanities1

Quality of Life

Information Science6

Survival Rate Registries Incidence Questionnaires SEER Program Base Sequence

Named Groups1

Health Care40

Follow-Up Studies Treatment Outcome Retrospective Studies Disease-Free Survival Survival Analysis Survival Rate Risk Factors Proportional Hazards Models Prospective Studies Kaplan-Meier Estimate Risk Assessment Predictive Value of Tests Risk Multivariate Analysis Cohort Studies Registries Sensitivity and Specificity Odds Ratio Age Factors Incidence Questionnaires Reproducibility of Results Regression Analysis Randomized Controlled Trials as Topic National Cancer Institute (U.S.)ROC Curve Analysis of Variance Models, Statistical Clinical Trials as Topic Case-Control Studies Body Mass Index Logistic Models SEER Program Confidence Intervals Chi-Square Distribution American Cancer Society Palliative Care Probability Genetic Testing Age Distribution

Geographicals4

United States Denmark Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Neoplasm Recurrence, Local Recurrence Breast Neoplasms Prognosis Prostatic Neoplasms Neoplasm Staging Tamoxifen Tumor Markers, Biological Follow-Up Studies Treatment Outcome Chemotherapy, Adjuvant Retrospective Studies Disease-Free Survival Antineoplastic Agents, Hormonal Prostatectomy Neoplasm Metastasis Survival Analysis Urinary Bladder Neoplasms Survival Rate Colonic Neoplasms Survivors Risk Factors Prostate-Specific Antigen Mastectomy, Extended Radical Proportional Hazards Models Radiotherapy, Adjuvant Combined Modality Therapy Prospective Studies Early Detection of Cancer Kaplan-Meier Estimate Stomach Neoplasms Neoplasm Invasiveness Neoplasms Lung Neoplasms Risk Assessment Gene Expression Regulation, Neoplastic Ovarian Neoplasms Receptors, Estrogen Colorectal Neoplasms Predictive Value of Tests Adenocarcinoma Risk Disease Progression Time Factors Antineoplastic Combined Chemotherapy Protocols Cystoscopy Rectal Neoplasms Cytochrome P-450 CYP2D6 Multivariate Analysis Mastectomy, Segmental Lymphatic Metastasis Cancer Vaccines Cohort Studies Carcinoma Gastrectomy Carcinoma, Squamous Cell Mastectomy Receptors, Progesterone Cell Line, Tumor Neoplastic Stem Cells Antineoplastic Agents Registries Ultrasound, High-Intensity Focused, Transrectal Gene Expression Profiling Cystectomy Sensitivity and Specificity Selective Estrogen Receptor Modulators Tomography, X-Ray Computed Receptor, erbB-2 Drug Resistance, Neoplasm Aromatase Inhibitors Odds Ratio Immunohistochemistry Positron-Emission Tomography United States Postmenopause Fluorouracil Age Factors Pancreatic Neoplasms Tissue Array Analysis Lymph Node Excision Carcinoma, Lobular Liver Neoplasms Mice, Nude Carcinoma, Transitional Cell Incidence Prostate Lymph Nodes Neoplasm Proteins Uterine Cervical Neoplasms Quality of Life Nitriles Cell Proliferation Questionnaires Denmark Oligonucleotide Array Sequence Analysis Carcinoma, Ductal, Breast Reproducibility of Results Genetic Predisposition to Disease Regression Analysis

No FAQ available that match "risk of cancer recurrence"